Drug intelligence / Profile preview

Nutraplete

Development stage: Unknown
Lead developer: Galea Life Sciences
Administration: Oral

Overview

Nutraplete is a therapeutic dietary supplement specifically formulated for individuals living with HIV/AIDS. Developed by Galea Life Sciences, it is designed to provide nutritional support to address the unique metabolic and health needs of this patient population. Unlike traditional pharmaceutical drugs, Nutraplete does not contain a single active pharmaceutical ingredient but rather a blend of nutritional components intended to support overall health. In November 2007, Galea Life Sciences entered into an exclusive distribution agreement with Allion Healthcare for the product. It was marketed as the first therapeutic dietary supplement specifically targeting the HIV/AIDS population.

Brand names: Nutraplete

Beyond the preview

Go deeper on Nutraplete.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nutraplete.

Explore the full profile